Vinblastine (Velban®) for Dogs and Cats

Overview of Vinblastine (Velban®) for Dogs and Cats

Vinblastine, also known by the brand name Velban®, is a cancer dug used to treat a variety of tumors in dogs and cats.
Vinblastine belongs to a group of medications known as vinca alkaloids and is obtained from the plant Cantharanthus roseus.
The drug is commonly used in the treatment of cancer. One of the hallmarks of cancer is the speed at which cancer cells divide. Vinblastine will bind to the proteins of actively dividing cells, preventing cell division and resulting in cell death.
Since cancer cells tend to divide rapidly, the drug will primarily effect these cells. Unfortunately, certain other body cells also divide rapidly, such a hair and gastrointestinal lining cells, resulting in effects on these sites of the body as well.
Vinblastine is a prescription drug and can only be obtained from a veterinarian or by prescription from a veterinarian.
This drug is not approved for use in animals by the Food and Drug Administration but it is prescribed legally by veterinarians as an extra-label drug.

Vinblastine is used to treat malignant cancers such as lymphoma, mast cell tumors, splenic tumors as well as other types of cancer.

While generally safe and effective when prescribed by a veterinarian, vinblastine can cause side effects in some animals.
Vinblastine should not be used in animals with known hypersensitivity or allergy to the drug.
Vinblastine should also be avoided in animals with liver disease, low white blood cell counts, preexisting leukemia or active infections.
Vinblastine may interact with other medications. Consult with your veterinarian to determine if other drugs your pet is receiving could interact with vinblastine. Drugs may include amiodarone, carvedilol, spironolactone, verapamil, diltiazem, erythromycin,and cyclosporine.
This drug should be used with caution in Collies that may have gene mutation MDR1 or ABCB1.
This drug has been shown to suppress the immune system in some animals.
Vinblastine may cause hair loss, vomiting, nausea, constipation, or diarrhea.
Constipation, jaw pain and irritation within the mouth may also occur.
This medication should only be given intravenous. If injected outside the vein, significant inflammation, including skin necrosis or sloughing, may occur.

Vinblastine is available in injectable form only at a concentration of 1 mg/ml in 10 ml and 25 ml vials.

Medication should never be administered without first consulting your veterinarian.
Vinblastine is administered in a hospital setting and is not prescribed for home use.
Vinblastine is commonly used in combination with other drugs to treat cancerous processes at a dose of 2 mg/m2 intravenous every 7 to 14 days in both cats and dogs. It can also be used for 4 consecutive days every 3 weeks.
The duration of administration depends on the condition being treated, response to the medication and the development of any adverse effects.